CXCR2 and COVID-19: For CD4+ T cells, an increase in frequencies of CXCR2+ CD74+ cells was found in both mild and severe COVID-19 compared to healthy controls (mean: healthy: 17.7%, mild 46.9%, severe 42.9%).